At Servier Pharmaceuticals, we are dedicated to bringing the promise of tomorrow to the patients we serve.
We are a commercial stage, privately held United States pharmaceutical company. Launched by Servier Group, a unique global organization operating in more than 150 countries and governed by a non-profit foundation, Servier Pharmaceuticals has the resources and network of an established global pharmaceutical company, while operating with the nimble and entrepreneurial spirit of a biotech.
Currently, oncology treatment and care are our immediate focus. We have two products on the market for acute lymphoblastic leukemia (ALL) a rare blood cancer, and plans to expand into other therapeutic areas.